Posted Jun. 19, 2012 at 7:00 a.m.
Biotech
Research and development spending by biotechnology firms increased 9 percent in 2011 with 62 percent of public companies increasing their investment spending, Ernst & Young says in annual biotech report.
Biotech R&D spending rebounds strongly in 2011, report says
Post a comment
Print this blog postE-mail blog post
Share
Biotech
Research and development spending by biotechnology firms increased 9 percent in 2011 with 62 percent of public companies increasing their investment spending, Ernst & Young says in annual biotech report.
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire. All rights reserved.Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Raleigh-based PRA International eyes public offering- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows
- Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
- Triangle politician tries to accelerate crowdfunding; bill passes first hurdle
- ChannelAdvisor seeks $80M, sets share target price for IPO
- IT job openings 28% below 2012 numbers, report shows